Jinghui Hong

The First Hospital of Jilin University

Jinghui Hong, MD, is an attending physician and lecturer at The First Hospital of Jilin University, and also serves as an honorary research associate at the University of Bristol, UK. His work bridges clinical practice and translational research in oncology, with a focus on addressing critical challenges in cancer treatment. Dr. Hong's primary research centers on the mechanisms of tumor drug resistance, a major obstacle to effective cancer therapy. His investigations explore the molecular and cellular adaptations that enable cancer cells to evade chemotherapy, targeted therapy, and immunotherapy. Utilizing a multidisciplinary approach that includes in vitro models, patient-derived samples, and bioinformatic analyses, he aims to identify novel biomarkers of resistance and uncover actionable therapeutic targets to overcome treatment resistance. Ultimately, his work strives to translate these discoveries into clinically applicable strategies to improve outcomes for patients with refractory or relapsed cancers. Committed to collaborative and interdisciplinary science, Dr. Hong is dedicated to advancing oncology research in ways that directly address unmet needs in clinical practice.